Aaron Lorenzo

Praecis Gets First Approval: Plenaxis In Prostate Cancer

Dec. 1, 2003

Prostate cancer patients gained a new treatment option on Nov. 25 as the FDA approved Plenaxis, a drug fully developed by Praecis Pharmaceuticals Inc. (BioWorld Today)

Pain Therapeutics Compound Begins Pivotal Program In IBS

Nov. 26, 2003

By Aaron Lorenzo

Pain Therapeutics Compound Begins Pivotal Program In IBS

Nov. 26, 2003

By Aaron Lorenzo

Genzyme Begins Pivotal Study To Broaden Synvisc's Labeling

Nov. 25, 2003

By Aaron Lorenzo

PPD Buying $25M Of Syrrx Stock As Part Of Diabetes Collaboration

Nov. 21, 2003

By Aaron Lorenzo

PPD Inc. is taking a stake in privately held Syrrx Inc. as part of a drug development deal. The companies agreed to partner their resources in further developing Syrrx-designed human dipeptidyl peptidase-IV (DP4) inhibitors for Type II diabetes and other diseases. (BioWorld Today)

Telik Presents Multiple Telcyta Studies In Ovarian, Lung Cancer

Nov. 21, 2003

By Aaron Lorenzo

Telik Presents Multiple Telcyta Studies In Ovarian, Lung Cancer

Nov. 21, 2003

By Aaron Lorenzo

PPD Buying $25M Of Syrrx Stock As Part Of Diabetes Collaboration

Nov. 21, 2003

By Aaron Lorenzo

PPD Inc. is taking a stake in privately held Syrrx Inc. as part of a drug development deal. The companies agreed to partner their resources in further developing Syrrx-designed human dipeptidyl peptidase-IV (DP4) inhibitors for Type II diabetes and other diseases. (BioWorld Today)